Woburn firm awarded contract to develop continuous US-based manufacturing capability

Date Published09/03/2021
Author NamePAT BLAI
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Continuus Pharmaceuticals
Parent companyContinuus Pharmaceuticals
Type of work Manufacturing
Reshoring category:Reshoring
What product(s) and/or service(s) were outsourced domestically?Manufacturing
Year reshoring announced:2021
Year reshoring implemented or to be implemented:2021
Domestically, the work will be done:In-house
Capital investment ($):85
City reshored to:Woburn
State(s) reshored to:MA
If relevant, work nearshored to:-
Industry(ies):Medical Equipment & Supplies
Product(s) reshoredpharmaceutical
What domestic positive factors made reshoring more attractive?Government Incentives, U.S. Department of Defense
Government Incentive dollar amount:$70 million
Find Reshoring Articles